Method of diagnosis of a predisposition to develop thrombotic disease and its uses

Details for Australian Patent Application No. 2005229374 (hide)

Owner Sanofi-Aventis Deutschland GmbH

Inventors Deleuze, Jean-Francois; Mace, Sandrine; Ricard, Sylvain; Herrmann, Matthias; Kozian, Detlef

Agent Watermark

Pub. Number AU-B-2005229374

PCT Pub. Number WO2005/095642

Priority 04007511.1 29.03.04 EP; 60/605,757 31.08.04 US

Filing date 16 March 2005

Wipo publication date 13 October 2005

Acceptance publication date 23 December 2010

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

Event Publications

26 October 2006 PCT application entered the National Phase

  PCT publication WO2005/095642 Priority application(s): WO2005/095642

23 December 2010 Application Accepted

  Published as AU-B-2005229374

21 April 2011 Standard Patent Sealed

11 October 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005229381-Swimming aid

2005229364-Plants with increased activity of multiple starch phosphorylating enzymes